PMC:7376974 / 93007-93258
Annnotations
LitCovid-PD-FMA-UBERON
| Id | Subject | Object | Predicate | Lexical cue | fma_id |
|---|---|---|---|---|---|
| T442 | 122-126 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
| T443 | 130-134 | Body_part | denotes | cell | http://purl.org/sig/ont/fma/fma68646 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 1659 | 211-215 | Species | denotes | mice | Tax:10090 |
| 1660 | 224-229 | Species | denotes | HSV-1 | Tax:10298 |
| 1661 | 30-43 | Chemical | denotes | CpGm adjuvant |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T855 | 62-70 | http://purl.obolibrary.org/obo/PR_000018263 | denotes | peptides |
| T856 | 122-126 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T857 | 130-134 | http://purl.obolibrary.org/obo/GO_0005623 | denotes | cell |
| T858 | 135-140 | http://purl.obolibrary.org/obo/NCBITaxon_10239 | denotes | virus |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T7076 | 35-43 | Chemical | denotes | adjuvant | http://purl.obolibrary.org/obo/CHEBI_60809 |
| T89486 | 62-70 | Chemical | denotes | peptides | http://purl.obolibrary.org/obo/CHEBI_16670 |
| T84988 | 74-82 | Chemical | denotes | antigens | http://purl.obolibrary.org/obo/CHEBI_59132 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T560 | 3-83 | Sentence | denotes | CaPNPs functionalized with CpGm adjuvant and two different peptides as antigens. |
| T561 | 84-94 | Sentence | denotes | Top right: |
| T562 | 95-157 | Sentence | denotes | CaPNPs were able to reduce cell-to-cell virus spread in vitro. |
| T563 | 158-171 | Sentence | denotes | Bottom right: |
| T564 | 172-230 | Sentence | denotes | CaP nanovaccines were able to immunize mice against HSV-1. |